Patents by Inventor Yuan-Shan Zeng

Yuan-Shan Zeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180105795
    Abstract: An extracellular matrix-modified decellularized nerve scaffold and use thereof are provided. The extracellular matrix-modified decellularized nerve scaffold is prepared from a natural porcine optic nerve. The scaffold has a plurality of longitudinal channels and a plurality of transversal foramina intercommunicated with the longitudinal channels, which have relatively uniform diameters and relatively even distributions in the scaffold. The extracellular matrix-modified decellularized optic nerve scaffold of the present invention changes the poor microenvironment of existing decellularized material that lacks cell growth factors and nutrients, supports seeded cells to form neural networks in vitro or in vivo, and enables the connection of ascending nerve fibers or descending nerve fibers of the injured spinal cord to their target cells after transplantation.
    Type: Application
    Filed: October 12, 2017
    Publication date: April 19, 2018
    Inventors: Yuan-shan Zeng, Ge Li, Jia-hui Sun
  • Publication number: 20080038288
    Abstract: The present invention provides a method for preventing or ameliorating neural damage in a mammalian fetus or a newborn infant, which is caused by maternal gestational hypertension (GH). The method includes orally administering germination activated sporoderm-broken Ganoderma lucidum spores (“GLSs”) to a pregnant mammal having GH. The neural damage includes a decrease in hippocampal cell proliferation and neuron number. The present invention further provides a method for preventing or ameliorating the increased expression of hippocampal hypoxia inducible factor (HIF-1a) and vascular endothelial growth factor (VEGF) in a mammalian embryo caused by maternal GH.
    Type: Application
    Filed: August 14, 2006
    Publication date: February 14, 2008
    Inventors: Chee-Keung Chung, Yuan-Shan Zeng
  • Publication number: 20060269568
    Abstract: The present invention provides a method for preventing and reducing embryonic neural tube defects (NTDs) caused by cell cycle arrest in the neuroepithelial cells of the embryo. The method comprises administering germination activated sporoderm-broken Ganoderma lucidum spores (“GLSs”) to a female mammal capable of becoming pregnant an effect amount of GLSs. GLSs are preferred to be administered to the female mammal prior to or at an early stage of the pregnancy. The GLSs reduce embryonic NTDs caused by cell cycle arrest in the neuroepithelial cells.
    Type: Application
    Filed: August 10, 2006
    Publication date: November 30, 2006
    Inventors: Chee-Keung Chung, Yuan-Shan Zeng